Related Experiment Videos
Origin and utility of the reverse dot-blot.
1Human Genetics Section, Laboratory of Genomic Diversity, National Cancer Institute at Frederick, MD 21702, USA. goldb@ncifcrf.gov
Expert Review of Molecular Diagnostics
|March 22, 2003
Summary
Reverse allele specific oligonucleotide assays offer a fast and accurate method for identifying genetic mutations. This technology enables rapid screening for inherited diseases like cystic fibrosis and hemoglobinopathies.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- Reverse allele specific oligonucleotide (RASO) assays are effective for characterizing genetic disorders with high mutation spectra.
- Commercial RASO tests are available for human leukocyte antigens (HLA), cystic fibrosis transmembrane conductance regulator (CFTR), and hepatitis B and C viruses.
Observation:
- RASO assays utilize multiplexed PCR with biotinylated primers for nonradioactive detection.
- Sophisticated reverse dot-blot technology immobilizes oligonucleotide probes onto membranes for hybridization.
- Detection involves colorimetric or chemiluminescent methods using enzyme conjugates and substrates.
Findings:
- The entire process, from blood sample to result, typically takes less than a day.
- High sensitivity and specificity allow for rapid screening of large populations.
- Automated instruments and scanning software enhance efficiency and genotype interpretation.
Implications:
- RASO technology is particularly valuable for prenatal diagnosis of genetic diseases such as cystic fibrosis, beta-thalassemia, and hemoglobinopathies.
- Its speed and accuracy facilitate timely genetic disease diagnosis and management.
- The technology supports broad applications in molecular diagnostics and personalized medicine.